Cannabis use patterns among emerging adults in California who use tobacco: Differences by sexual identity, gender identity, and sex assigned at birth

Q1 Psychology

Addictive Behaviors Reports Pub Date : 2025-07-14 DOI:10.1016/j.abrep.2025.100624

Evan A. Krueger , Luisita Cordero , Chenglin Hong , Risa Flynn , Ian W. Holloway

{"title":"Cannabis use patterns among emerging adults in California who use tobacco: Differences by sexual identity, gender identity, and sex assigned at birth","authors":"Evan A. Krueger , Luisita Cordero , Chenglin Hong , Risa Flynn , Ian W. Holloway","doi":"10.1016/j.abrep.2025.100624","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Sexual and/or gender minority (SGM) emerging adults use both cannabis and tobacco products at higher rates than their non-SGM peers. Co-use of cannabis and tobacco is of increasing public health concern, yet relatively little is known about co-use among SGM emerging adults.</div></div><div><h3>Methods</h3><div>Data were from a cross-sectional survey (2020 – 2021) of 1,467 SGM (n = 868) and non-SGM (n = 623) emerging adults from California. To be eligible, participants reported using at least one tobacco product in the prior 30 days. We assessed differences in lifetime and recent (past 3-month) cannabis use, and in concurrent use of both substances, across six groups: cisgender heterosexual, cisgender sexual minority (SM), transgender/gender non-conforming (TGNC) participants assigned female at birth (AFAB), and cisgender heterosexual, cisgender SM, and TGNC participants assigned male at birth (AMAB).</div></div><div><h3>Results</h3><div>Among AFAB, cisgender SM and TGNC participants (vs. cisgender heterosexual) had higher odds of lifetime (cisgender SM: aOR = 2.38, 95 % CI = 1.54, 3.72; TGNC: aOR = 1.97, 95 % CI = 1.17, 3.40) and recent cannabis use (cisgender SM: aOR = 1.72, 95 % CI = 1.29, 2.30; TGNC: aOR = 1.83, 95 % CI = 1.29, 2.61), and of concurrent use (cisgender SM: aOR = 1.49, 95 % CI = 1.11, 2.00; TGNC: aOR = 1.98, 95 % CI = 1.39, 2.82). No differences in cannabis and tobacco co-use were noted among AMAB.</div></div><div><h3>Conclusion</h3><div>Cisgender SM and TGNC AFAB are at high risk for cannabis and tobacco co-use. Prevention and harm reduction interventions should be tailored to these groups.</div></div>","PeriodicalId":38040,"journal":{"name":"Addictive Behaviors Reports","volume":"22 ","pages":"Article 100624"},"PeriodicalIF":0.0000,"publicationDate":"2025-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Addictive Behaviors Reports","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2352853225000422","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Psychology","Score":null,"Total":0}

引用次数: 0

Abstract

Background

Sexual and/or gender minority (SGM) emerging adults use both cannabis and tobacco products at higher rates than their non-SGM peers. Co-use of cannabis and tobacco is of increasing public health concern, yet relatively little is known about co-use among SGM emerging adults.

Methods

Data were from a cross-sectional survey (2020 – 2021) of 1,467 SGM (n = 868) and non-SGM (n = 623) emerging adults from California. To be eligible, participants reported using at least one tobacco product in the prior 30 days. We assessed differences in lifetime and recent (past 3-month) cannabis use, and in concurrent use of both substances, across six groups: cisgender heterosexual, cisgender sexual minority (SM), transgender/gender non-conforming (TGNC) participants assigned female at birth (AFAB), and cisgender heterosexual, cisgender SM, and TGNC participants assigned male at birth (AMAB).

Results

Among AFAB, cisgender SM and TGNC participants (vs. cisgender heterosexual) had higher odds of lifetime (cisgender SM: aOR = 2.38, 95 % CI = 1.54, 3.72; TGNC: aOR = 1.97, 95 % CI = 1.17, 3.40) and recent cannabis use (cisgender SM: aOR = 1.72, 95 % CI = 1.29, 2.30; TGNC: aOR = 1.83, 95 % CI = 1.29, 2.61), and of concurrent use (cisgender SM: aOR = 1.49, 95 % CI = 1.11, 2.00; TGNC: aOR = 1.98, 95 % CI = 1.39, 2.82). No differences in cannabis and tobacco co-use were noted among AMAB.

Conclusion

Cisgender SM and TGNC AFAB are at high risk for cannabis and tobacco co-use. Prevention and harm reduction interventions should be tailored to these groups.

查看原文本刊更多论文

加州新成年吸烟者的大麻使用模式：性别认同、性别认同和出生时生理性别的差异

性和/或性别少数群体（SGM）新兴成年人使用大麻和烟草产品的比例高于非SGM同龄人。大麻和烟草的共同使用日益引起公共卫生关注，但对SGM新生成人的共同使用情况知之甚少。方法数据来自一项横断面调查（2020 - 2021），调查对象为1467名来自加州的SGM （n = 868）和非SGM （n = 623）初生成人。为了符合条件，参与者报告在过去30天内至少使用过一种烟草产品。我们评估了一生和最近（过去3个月）大麻使用的差异，以及同时使用两种物质的差异，分为六组：顺性异性恋者，顺性性少数群体（SM），变性/性别不符合者（TGNC）出生时被指定为女性（AFAB），顺性异性恋者，顺性SM和TGNC出生时被指定为男性（AMAB）。结果在AFAB中，顺性SM和TGNC参与者（相对于顺性异性恋者）的终生患病率更高(顺性SM: aOR = 2.38, 95% CI = 1.54, 3.72；TGNC: aOR = 1.97, 95% CI = 1.17, 3.40)和近期大麻使用情况(顺性别SM: aOR = 1.72, 95% CI = 1.29, 2.30；TGNC: aOR = 1.83, 95% CI = 1.29, 2.61)和同时使用(顺性别SM: aOR = 1.49, 95% CI = 1.11, 2.00；TGNC: aOR = 1.98, 95% CI = 1.39, 2.82)。在AMAB中，大麻和烟草的共同使用没有差异。结论同性SM和TGNC型AFAB是大麻和烟草共同使用的高危人群。预防和减少伤害的干预措施应针对这些群体。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Addictive Behaviors Reports Medicine-Psychiatry and Mental Health

CiteScore

6.80

自引率

0.00%

发文量

审稿时长

71 days

期刊介绍： Addictive Behaviors Reports is an open-access and peer reviewed online-only journal offering an interdisciplinary forum for the publication of research in addictive behaviors. The journal accepts submissions that are scientifically sound on all forms of addictive behavior (alcohol, drugs, gambling, Internet, nicotine and technology) with a primary focus on behavioral and psychosocial research. The emphasis of the journal is primarily empirical. That is, sound experimental design combined with valid, reliable assessment and evaluation procedures are a requisite for acceptance. We are particularly interested in ''non-traditional'', innovative and empirically oriented research such as negative/null data papers, replication studies, case reports on novel treatments, and cross-cultural research. Studies that might encourage new lines of inquiry as well as scholarly commentaries on topical issues, systematic reviews, and mini reviews are also very much encouraged. We also welcome multimedia submissions that incorporate video or audio components to better display methodology or findings.